Lewis H Bender insider trades

Open-market stock purchases and sales by Lewis H Bender, President and CEO at Intensity Therapeutics, Inc, from SEC Form 4 filings since Jan 21, 2010.

Recent trades

DateStockTradeValue
Jul 16, 2026INTS Intensity Therapeutics, IncBought (not open market)—
Mar 26, 2026INTS Intensity Therapeutics, IncBought (not open market)$231K

Companies traded

  • INTS Intensity Therapeutics, Inc: other filings, last Jul 16, 2026
  • ILIU Interleukin Genetics Inc: other filings, last Feb 14, 2011
  • ILI Interleukin Genetics Inc: other filings, last Jan 21, 2010

Get free alerts when Lewis H Bender files a new trade →